D Focosi, A Casadevall, M Franchini, F Maggi - Viruses, 2024 - ncbi.nlm.nih.gov
Among the anti-Spike monoclonal antibodies (mAbs), the S-309 derivative sotrovimab was
the most successful in having the longest temporal window of clinical use, showing a high …